Table 1.
Marker | Significance | Cell lines/Specimens | Ref. |
---|---|---|---|
CD24 | Cytoplasmic localisation of CD24+ is indicative of poor prognosis and predictive of recurrence | Human ovarian serous tumours | [16] |
Increased metastasis and chemoresistance in CD24+ cells that have developed cisplatin-resistance | CAOV-3 cell line | [17] | |
CD44 | CD44+/CD24- expression in cells is predictive of recurrence | Human OC cells isolated from ascites | [18] |
CD117 | CD117+/c-Kit+ expression in cells is characteristic of chemoresistance | Human advanced serous ovarian carcinoma | [19] |
Therapy with paclitaxel increases CD177 expression in vivo | Primary tumour xenografts | [20] | |
CD133 | Higher cisplatin IC50 in CD133+ cells characteristic of chemoresistance | 42 established OC cell lines | [21] |
ALDH | ALDH1A1 expression in OCSCs correlates with poor survival and chemoresistance | Human high-grade OC tumours | [13] |
OC: ovarian cancer; OCSCs: ovarian cancer stem cells